COMMUNIQUÉS West-GlobeNewswire

CAMP4 to Participate in Upcoming Investor Conferences
01/09/2026
WATERTOWN, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting [...]
Cytek Biosciences to Participate in Upcoming Investor Conferences
01/09/2026
FREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor [...]
Sana Biotechnology to Present at September 2026 Investor Conferences
01/09/2026
SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]
Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15
01/09/2026
MENLO PARK, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, [...]
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
01/09/2026
SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical [...]
LifeStance to Present at Upcoming Investor Conferences
01/09/2026
SCOTTSDALE, Ariz., Sept. 01, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced that management will present at [...]
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Chris [...]
Aura Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA) (“Aura” or the “Company”), a clinical-stage biotechnology company developing a potentially transformative first-in-class therapy for [...]
Braveheart Bio to Participate in Cantor Global Healthcare Conference
01/09/2026
SAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other [...]
Tarsus to Participate in Upcoming Investor Conferences
01/09/2026
IRVINE, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to attend the following upcoming investor conferences: Wells Fargo 21 st Annual [...]
Teva to Present at Morgan Stanley, J.P. Morgan and BofA Investor Conferences in September
01/09/2026
TEL AVIV, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at three upcoming investor [...]
Cellectis annonce sa participation à plusieurs conférences investisseurs
01/09/2026
NEW YORK, 01 sept. 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth : ALCLS ; Nasdaq : CLLS), société de biotechnologie de stade clinique, qui utilise sa plateforme pionnière d'édition de génome pour développer des [...]
Cellectis Announces Participation in Upcoming Investor Conferences
01/09/2026
NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving [...]
STERIS to Present at the Morgan Stanley Healthcare Conference
01/09/2026
Dublin, Ireland, Sept. 01, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will participate in the Morgan Stanley Healthcare Conference in New York City on Tuesday, [...]
aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
01/09/2026
Company anticipates response from FDA by mid-September 2026 on protocol submitted for planned Phase 3 study of efzofitimod in patients with pulmonary sarcoidosis with restrictive lung disease. SAN DIEGO, Sept. 01, 2026 [...]
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
01/09/2026
CAMBRIDGE, Mass., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients [...]
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/09/2026
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
HWH International Inc. Announces Executive Leadership Transition
01/09/2026
BETHESDA, MD, Sept. 01, 2026 (GLOBE NEWSWIRE) -- HWH International Inc. (Nasdaq: HWH) ("HWH" or the "Company") today announced a transition in its executive leadership. Chan Heng Fai (“ Mr. Chan ”), the Company's [...]
Pennant Group to Participate in the 2026 Jefferies Healthcare Services Conference
02/09/2026
EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]

Pages